|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-0.54/--
|
Enterprise Value
101.81M
|
Balance Sheet |
Book Value Per Share
4.49
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
57.08M
|
Operating Revenue Per Share
3.48
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
![](../images/dot.bmp)
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel. |